nodes	percent_of_prediction	percent_of_DWPC	metapath
Acenocoumarol—ORM1—Erlotinib—pancreatic cancer	0.181	0.211	CbGbCtD
Acenocoumarol—ALB—Erlotinib—pancreatic cancer	0.0763	0.0889	CbGbCtD
Acenocoumarol—ALB—Irinotecan—pancreatic cancer	0.0689	0.0803	CbGbCtD
Acenocoumarol—CYP1A2—Dacarbazine—pancreatic cancer	0.0675	0.0786	CbGbCtD
Acenocoumarol—ALB—Fluorouracil—pancreatic cancer	0.0661	0.077	CbGbCtD
Acenocoumarol—CYP2C19—Tamoxifen—pancreatic cancer	0.0582	0.0678	CbGbCtD
Acenocoumarol—CYP1A2—Tamoxifen—pancreatic cancer	0.0537	0.0625	CbGbCtD
Acenocoumarol—CYP2C9—Tamoxifen—pancreatic cancer	0.0484	0.0564	CbGbCtD
Acenocoumarol—CYP1A2—Erlotinib—pancreatic cancer	0.0456	0.0532	CbGbCtD
Acenocoumarol—CYP1A2—Fluorouracil—pancreatic cancer	0.0396	0.0461	CbGbCtD
Acenocoumarol—CYP2C9—Fluorouracil—pancreatic cancer	0.0356	0.0415	CbGbCtD
Acenocoumarol—CYP3A4—Tamoxifen—pancreatic cancer	0.0281	0.0328	CbGbCtD
Acenocoumarol—CYP3A4—Erlotinib—pancreatic cancer	0.0239	0.0279	CbGbCtD
Acenocoumarol—CYP3A4—Irinotecan—pancreatic cancer	0.0216	0.0252	CbGbCtD
Acenocoumarol—CYP3A4—Docetaxel—pancreatic cancer	0.0158	0.0184	CbGbCtD
Acenocoumarol—CYP3A4—Sunitinib—pancreatic cancer	0.0158	0.0184	CbGbCtD
Acenocoumarol—CYP3A4—Doxorubicin—pancreatic cancer	0.0118	0.0137	CbGbCtD
Acenocoumarol—Appetite absent—Tamoxifen—pancreatic cancer	0.00586	0.0446	CcSEcCtD
Acenocoumarol—ORM1—bile—pancreatic cancer	0.00523	0.499	CbGeAlD
Acenocoumarol—Metrorrhagia—Sunitinib—pancreatic cancer	0.0035	0.0266	CcSEcCtD
Acenocoumarol—Liver injury—Tamoxifen—pancreatic cancer	0.00347	0.0264	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Tamoxifen—pancreatic cancer	0.00292	0.0222	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Erlotinib—pancreatic cancer	0.00289	0.022	CcSEcCtD
Acenocoumarol—Melaena—Erlotinib—pancreatic cancer	0.00282	0.0215	CcSEcCtD
Acenocoumarol—Skin exfoliation—Tamoxifen—pancreatic cancer	0.00278	0.0212	CcSEcCtD
Acenocoumarol—Skin exfoliation—Erlotinib—pancreatic cancer	0.00276	0.021	CcSEcCtD
Acenocoumarol—Skin necrosis—Epirubicin—pancreatic cancer	0.00275	0.0209	CcSEcCtD
Acenocoumarol—Neoplasm—Tamoxifen—pancreatic cancer	0.00264	0.0201	CcSEcCtD
Acenocoumarol—Skin necrosis—Doxorubicin—pancreatic cancer	0.00254	0.0194	CcSEcCtD
Acenocoumarol—Melaena—Sunitinib—pancreatic cancer	0.00244	0.0186	CcSEcCtD
Acenocoumarol—Skin exfoliation—Sunitinib—pancreatic cancer	0.00239	0.0182	CcSEcCtD
Acenocoumarol—Neoplasm—Sunitinib—pancreatic cancer	0.00226	0.0172	CcSEcCtD
Acenocoumarol—Ulcer—Irinotecan—pancreatic cancer	0.00218	0.0166	CcSEcCtD
Acenocoumarol—Ulcer—Gemcitabine—pancreatic cancer	0.00212	0.0161	CcSEcCtD
Acenocoumarol—Ulcer—Fluorouracil—pancreatic cancer	0.00208	0.0159	CcSEcCtD
Acenocoumarol—Skin exfoliation—Gemcitabine—pancreatic cancer	0.00191	0.0146	CcSEcCtD
Acenocoumarol—Neoplasm—Irinotecan—pancreatic cancer	0.00186	0.0142	CcSEcCtD
Acenocoumarol—Haemoglobin—Tamoxifen—pancreatic cancer	0.00147	0.0112	CcSEcCtD
Acenocoumarol—Haemorrhage—Tamoxifen—pancreatic cancer	0.00146	0.0112	CcSEcCtD
Acenocoumarol—Haemoglobin—Erlotinib—pancreatic cancer	0.00146	0.0111	CcSEcCtD
Acenocoumarol—ORM1—gall bladder—pancreatic cancer	0.00145	0.139	CbGeAlD
Acenocoumarol—Haemorrhage—Erlotinib—pancreatic cancer	0.00145	0.011	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Docetaxel—pancreatic cancer	0.00142	0.0108	CcSEcCtD
Acenocoumarol—Skin exfoliation—Docetaxel—pancreatic cancer	0.00136	0.0103	CcSEcCtD
Acenocoumarol—Alopecia—Tamoxifen—pancreatic cancer	0.00129	0.00986	CcSEcCtD
Acenocoumarol—Neoplasm—Docetaxel—pancreatic cancer	0.00129	0.0098	CcSEcCtD
Acenocoumarol—Alopecia—Erlotinib—pancreatic cancer	0.00128	0.00975	CcSEcCtD
Acenocoumarol—ALB—gall bladder—pancreatic cancer	0.00127	0.122	CbGeAlD
Acenocoumarol—Haemoglobin—Sunitinib—pancreatic cancer	0.00126	0.0096	CcSEcCtD
Acenocoumarol—Haemorrhage—Sunitinib—pancreatic cancer	0.00125	0.00956	CcSEcCtD
Acenocoumarol—VKORC1—pancreas—pancreatic cancer	0.00124	0.118	CbGeAlD
Acenocoumarol—Liver injury—Epirubicin—pancreatic cancer	0.00114	0.00868	CcSEcCtD
Acenocoumarol—Alopecia—Sunitinib—pancreatic cancer	0.00111	0.00844	CcSEcCtD
Acenocoumarol—Haematuria—Gemcitabine—pancreatic cancer	0.00107	0.00814	CcSEcCtD
Acenocoumarol—Liver injury—Doxorubicin—pancreatic cancer	0.00106	0.00804	CcSEcCtD
Acenocoumarol—Haemoglobin—Irinotecan—pancreatic cancer	0.00104	0.00791	CcSEcCtD
Acenocoumarol—Haemorrhage—Irinotecan—pancreatic cancer	0.00103	0.00787	CcSEcCtD
Acenocoumarol—Ulcer—Epirubicin—pancreatic cancer	0.00101	0.00773	CcSEcCtD
Acenocoumarol—Haemoglobin—Gemcitabine—pancreatic cancer	0.00101	0.00771	CcSEcCtD
Acenocoumarol—Haemorrhage—Gemcitabine—pancreatic cancer	0.00101	0.00767	CcSEcCtD
Acenocoumarol—Haemoglobin—Fluorouracil—pancreatic cancer	0.000995	0.00758	CcSEcCtD
Acenocoumarol—Haemorrhage—Fluorouracil—pancreatic cancer	0.00099	0.00754	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Epirubicin—pancreatic cancer	0.00096	0.00731	CcSEcCtD
Acenocoumarol—Ulcer—Doxorubicin—pancreatic cancer	0.000939	0.00715	CcSEcCtD
Acenocoumarol—Melaena—Epirubicin—pancreatic cancer	0.000937	0.00714	CcSEcCtD
Acenocoumarol—Skin exfoliation—Epirubicin—pancreatic cancer	0.000916	0.00698	CcSEcCtD
Acenocoumarol—Alopecia—Irinotecan—pancreatic cancer	0.000913	0.00696	CcSEcCtD
Acenocoumarol—Decreased appetite—Tamoxifen—pancreatic cancer	0.000905	0.00689	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000898	0.00684	CcSEcCtD
Acenocoumarol—Decreased appetite—Erlotinib—pancreatic cancer	0.000895	0.00682	CcSEcCtD
Acenocoumarol—Alopecia—Gemcitabine—pancreatic cancer	0.00089	0.00678	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000889	0.00677	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.000888	0.00676	CcSEcCtD
Acenocoumarol—Alopecia—Fluorouracil—pancreatic cancer	0.000875	0.00666	CcSEcCtD
Acenocoumarol—Neoplasm—Epirubicin—pancreatic cancer	0.000868	0.00661	CcSEcCtD
Acenocoumarol—Melaena—Doxorubicin—pancreatic cancer	0.000867	0.0066	CcSEcCtD
Acenocoumarol—Skin exfoliation—Doxorubicin—pancreatic cancer	0.000848	0.00646	CcSEcCtD
Acenocoumarol—Urticaria—Tamoxifen—pancreatic cancer	0.000827	0.0063	CcSEcCtD
Acenocoumarol—Body temperature increased—Erlotinib—pancreatic cancer	0.000814	0.0062	CcSEcCtD
Acenocoumarol—Neoplasm—Doxorubicin—pancreatic cancer	0.000803	0.00611	CcSEcCtD
Acenocoumarol—Decreased appetite—Sunitinib—pancreatic cancer	0.000775	0.0059	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00077	0.00586	CcSEcCtD
Acenocoumarol—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000767	0.00584	CcSEcCtD
Acenocoumarol—Haemoglobin—Docetaxel—pancreatic cancer	0.000718	0.00547	CcSEcCtD
Acenocoumarol—Haemorrhage—Docetaxel—pancreatic cancer	0.000714	0.00544	CcSEcCtD
Acenocoumarol—Diarrhoea—Tamoxifen—pancreatic cancer	0.000712	0.00542	CcSEcCtD
Acenocoumarol—Body temperature increased—Sunitinib—pancreatic cancer	0.000705	0.00537	CcSEcCtD
Acenocoumarol—Diarrhoea—Erlotinib—pancreatic cancer	0.000705	0.00537	CcSEcCtD
Acenocoumarol—Vomiting—Tamoxifen—pancreatic cancer	0.000662	0.00504	CcSEcCtD
Acenocoumarol—Hypersensitivity—Sunitinib—pancreatic cancer	0.000657	0.005	CcSEcCtD
Acenocoumarol—Dermatitis—Tamoxifen—pancreatic cancer	0.000656	0.00499	CcSEcCtD
Acenocoumarol—Vomiting—Erlotinib—pancreatic cancer	0.000655	0.00499	CcSEcCtD
Acenocoumarol—Dermatitis—Erlotinib—pancreatic cancer	0.000649	0.00494	CcSEcCtD
Acenocoumarol—Decreased appetite—Irinotecan—pancreatic cancer	0.000638	0.00486	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000634	0.00483	CcSEcCtD
Acenocoumarol—Alopecia—Docetaxel—pancreatic cancer	0.000631	0.00481	CcSEcCtD
Acenocoumarol—Decreased appetite—Gemcitabine—pancreatic cancer	0.000622	0.00474	CcSEcCtD
Acenocoumarol—Nausea—Tamoxifen—pancreatic cancer	0.000618	0.00471	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000617	0.0047	CcSEcCtD
Acenocoumarol—Nausea—Erlotinib—pancreatic cancer	0.000612	0.00466	CcSEcCtD
Acenocoumarol—Decreased appetite—Fluorouracil—pancreatic cancer	0.000611	0.00466	CcSEcCtD
Acenocoumarol—Diarrhoea—Sunitinib—pancreatic cancer	0.00061	0.00464	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000607	0.00462	CcSEcCtD
Acenocoumarol—Body temperature increased—Irinotecan—pancreatic cancer	0.00058	0.00442	CcSEcCtD
Acenocoumarol—Vomiting—Sunitinib—pancreatic cancer	0.000567	0.00432	CcSEcCtD
Acenocoumarol—Body temperature increased—Gemcitabine—pancreatic cancer	0.000565	0.00431	CcSEcCtD
Acenocoumarol—Dermatitis—Sunitinib—pancreatic cancer	0.000562	0.00428	CcSEcCtD
Acenocoumarol—Urticaria—Fluorouracil—pancreatic cancer	0.000559	0.00425	CcSEcCtD
Acenocoumarol—Body temperature increased—Fluorouracil—pancreatic cancer	0.000556	0.00423	CcSEcCtD
Acenocoumarol—Hypersensitivity—Irinotecan—pancreatic cancer	0.000541	0.00412	CcSEcCtD
Acenocoumarol—Nausea—Sunitinib—pancreatic cancer	0.000529	0.00403	CcSEcCtD
Acenocoumarol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000518	0.00395	CcSEcCtD
Acenocoumarol—Haematuria—Epirubicin—pancreatic cancer	0.000512	0.0039	CcSEcCtD
Acenocoumarol—Diarrhoea—Irinotecan—pancreatic cancer	0.000502	0.00383	CcSEcCtD
Acenocoumarol—Diarrhoea—Gemcitabine—pancreatic cancer	0.000489	0.00373	CcSEcCtD
Acenocoumarol—Haemoglobin—Epirubicin—pancreatic cancer	0.000484	0.00369	CcSEcCtD
Acenocoumarol—Haemorrhage—Epirubicin—pancreatic cancer	0.000482	0.00367	CcSEcCtD
Acenocoumarol—Diarrhoea—Fluorouracil—pancreatic cancer	0.000481	0.00366	CcSEcCtD
Acenocoumarol—Haematuria—Doxorubicin—pancreatic cancer	0.000474	0.00361	CcSEcCtD
Acenocoumarol—Vomiting—Irinotecan—pancreatic cancer	0.000467	0.00356	CcSEcCtD
Acenocoumarol—Dermatitis—Irinotecan—pancreatic cancer	0.000463	0.00352	CcSEcCtD
Acenocoumarol—Vomiting—Gemcitabine—pancreatic cancer	0.000455	0.00346	CcSEcCtD
Acenocoumarol—Dermatitis—Gemcitabine—pancreatic cancer	0.000451	0.00343	CcSEcCtD
Acenocoumarol—Haemoglobin—Doxorubicin—pancreatic cancer	0.000448	0.00341	CcSEcCtD
Acenocoumarol—Vomiting—Fluorouracil—pancreatic cancer	0.000447	0.00341	CcSEcCtD
Acenocoumarol—Haemorrhage—Doxorubicin—pancreatic cancer	0.000446	0.0034	CcSEcCtD
Acenocoumarol—Dermatitis—Fluorouracil—pancreatic cancer	0.000443	0.00337	CcSEcCtD
Acenocoumarol—Decreased appetite—Docetaxel—pancreatic cancer	0.000441	0.00336	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000438	0.00334	CcSEcCtD
Acenocoumarol—Nausea—Irinotecan—pancreatic cancer	0.000436	0.00332	CcSEcCtD
Acenocoumarol—Alopecia—Epirubicin—pancreatic cancer	0.000426	0.00324	CcSEcCtD
Acenocoumarol—Nausea—Gemcitabine—pancreatic cancer	0.000425	0.00324	CcSEcCtD
Acenocoumarol—Nausea—Fluorouracil—pancreatic cancer	0.000418	0.00318	CcSEcCtD
Acenocoumarol—CYP2C19—digestive system—pancreatic cancer	0.000404	0.0385	CbGeAlD
Acenocoumarol—Body temperature increased—Docetaxel—pancreatic cancer	0.000401	0.00306	CcSEcCtD
Acenocoumarol—Alopecia—Doxorubicin—pancreatic cancer	0.000394	0.003	CcSEcCtD
Acenocoumarol—Hypersensitivity—Docetaxel—pancreatic cancer	0.000374	0.00285	CcSEcCtD
Acenocoumarol—Diarrhoea—Docetaxel—pancreatic cancer	0.000347	0.00264	CcSEcCtD
Acenocoumarol—CYP1A2—digestive system—pancreatic cancer	0.00033	0.0314	CbGeAlD
Acenocoumarol—Vomiting—Docetaxel—pancreatic cancer	0.000323	0.00246	CcSEcCtD
Acenocoumarol—Dermatitis—Docetaxel—pancreatic cancer	0.00032	0.00244	CcSEcCtD
Acenocoumarol—CYP2C9—digestive system—pancreatic cancer	0.000313	0.0299	CbGeAlD
Acenocoumarol—Nausea—Docetaxel—pancreatic cancer	0.000301	0.0023	CcSEcCtD
Acenocoumarol—Decreased appetite—Epirubicin—pancreatic cancer	0.000298	0.00227	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000296	0.00225	CcSEcCtD
Acenocoumarol—Decreased appetite—Doxorubicin—pancreatic cancer	0.000275	0.0021	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000273	0.00208	CcSEcCtD
Acenocoumarol—Urticaria—Epirubicin—pancreatic cancer	0.000272	0.00207	CcSEcCtD
Acenocoumarol—Body temperature increased—Epirubicin—pancreatic cancer	0.000271	0.00206	CcSEcCtD
Acenocoumarol—Hypersensitivity—Epirubicin—pancreatic cancer	0.000252	0.00192	CcSEcCtD
Acenocoumarol—Urticaria—Doxorubicin—pancreatic cancer	0.000252	0.00192	CcSEcCtD
Acenocoumarol—Body temperature increased—Doxorubicin—pancreatic cancer	0.00025	0.00191	CcSEcCtD
Acenocoumarol—CYP3A4—digestive system—pancreatic cancer	0.000239	0.0228	CbGeAlD
Acenocoumarol—Diarrhoea—Epirubicin—pancreatic cancer	0.000234	0.00178	CcSEcCtD
Acenocoumarol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000233	0.00178	CcSEcCtD
Acenocoumarol—Vomiting—Epirubicin—pancreatic cancer	0.000218	0.00166	CcSEcCtD
Acenocoumarol—Diarrhoea—Doxorubicin—pancreatic cancer	0.000217	0.00165	CcSEcCtD
Acenocoumarol—Dermatitis—Epirubicin—pancreatic cancer	0.000216	0.00164	CcSEcCtD
Acenocoumarol—Nausea—Epirubicin—pancreatic cancer	0.000203	0.00155	CcSEcCtD
Acenocoumarol—Vomiting—Doxorubicin—pancreatic cancer	0.000201	0.00153	CcSEcCtD
Acenocoumarol—Dermatitis—Doxorubicin—pancreatic cancer	0.0002	0.00152	CcSEcCtD
Acenocoumarol—Nausea—Doxorubicin—pancreatic cancer	0.000188	0.00143	CcSEcCtD
